Compared to Estimates, TransMedics (TMDX) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2024, TransMedics (TMDX) reported revenue of $114.31 million, up 117.9% over the same period last year. EPS came in at $0.35, compared to -$0.03 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $98.63 million, representing a surprise of +15.89%. The company delivered an EPS surprise of +66.67%, with the consensus EPS estimate being $0.21. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall S ...